Synthetic biology: Below the radar [Book review] by Weitkamp, Emma
Synthetic biology: below the radar
ENGELHARD, M. ED. (2016). SYNTHETIC BIOLOGY ANALYSED: TOOLS FORBook
DISCUSSION AND EVALUATION. SPRINGER INTERNATIONAL.
Emma WeitkampReviewed by
Englehard et al provide a wide-ranging look at synthetic biology, from
discussion of how one might classify different synthetic approaches to
consideration of risk and ethical issues. The chapter on public engagement
considers why synthetic biology seems to sit below the public radar.
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How will synthetic biology shape our conceptions of life? This is just one of the
many ‘big’ questions raised in this collection of readings aimed at stimulating
discussion and providing an ‘interdisciplinary toolbox to facilitate and differentiate
its societal evaluation’ (p. vii). The book provides an interesting exploration of the
manifold social, ethical and legal issues raised by modern technology. Yes it focuses
on synthetic biology, but the issues raised apply to varying degrees to a wide range
of emerging technologies, such as robotics and nanotechnology.
What makes synthetic biology particularly interesting, though, is its potential to
change radically how we think about life, the questions it raises about risk analysis
and its, perhaps surprisingly low, public salience. Taking the ethical questions first,
Christian Illies, in the chapter New Debates in Old Ethical Skins asks whether
synthetic biology demands a new ethics. Having worked through issues related to
risk and uncertainty, global justice and the ‘playing God’ argument Illies considers
that at least at the moment ‘most challenges of synthetic biology are familiar in
principle. . . They do not require a new ethics if ‘new ethics’ is understood as a field
of new norms and values.’ (p. 110) But he does go on to suggest that synthetic
biology, as the ‘apogee of modern science and technology. . . might also be regarded
as an extreme case of uncertainty.’ (p.110) As such, it does warrant ethical debate
and Illies calls for this debate to happen before ‘before the developments of
synthetic biology urgently demand ethical or political answers’. (p.122).
Synthetic Biology Analysed is not an easy read and the book would certainly have
benefited from the services of a good editor. Part of the challenge is the wide range
of literature and research fields and traditions represented in the text. Not only
does it seek to explain the range of organisms we might classify as synthetic (and
how we might classify them), but also how we might develop an ethical framework
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to address synthetic biology, the types and nature of the risks that should be
considered, current public opinion research and what sort of legal framework we
might imagine for this emerging field. As such, it is a comprehensive introduction
to the subject.
Bölker, Engelhard and Budisa provide a useful way of conceptualising the different
strands of synthetic biology in chapter 2, Synthetic Biology: Diverse Layers of
Life. They describe three, increasingly challenging, branches of synthetic biology:
– Engineering approaches: in this conception, biology is transformed into an
engineering discipline, with standardised parts and building blocks (see for
example: biobricks.org) used to modify existing life forms (and presumably
potentially to build a new life form from scratch). Engineering approaches
stick fairly closely to natural systems; this presents both a risk — in that any
organisms created can potentially cross bread with natural organisms — and
a suggestion for risk assessment - in that we can use our knowledge of
natural systems as a guide.
– Orthogonal approaches: these approaches seek to reduce risk by creating
organisms unable cross breed with natural life forms, by introducing, for
example, synthetic nucleotides. The use of synthetic nucleotides creates, what
is referred to as ‘xeno-life’. Of course, such xeno-organisms could still
compete with natural organisms in the ecosystem, so are not without risk.
– Protocell research: drawing on evolutionary biology, protocell research seeks
to create simple cells that can perform at least some of the functions
associated with life (specifically metabolic functions). Protocell research is
often aimed at exploring the origins of life, but questions around risk remain.
Perhaps the most interesting and challenging chapter is that from Engelhard,
Bölker and Budisa exploring Old and New Risks in Synthetic Biology: Topics and
Tools for Discussion. The chapter explores whether our existing risk management
systems can be applied to synthetic biology and arguing that a multidisciplinary
approach to risk assessment, that takes account of the precautionary principle, is
needed. The chapter highlights the important role of perspective in shaping risk
discourses around synthetic biology: is it novel (i.e. risky) or just a continuation of
existing genetic research (i.e. lower risk). How the field presents its identity could
have a significant impact on how risks are assessed, particularly by nonspecialists.
The authors also highlight features of synthetic biology that present particular
challenges for risk assessment:
– the depth of the intervention: the authors argue that synthetic biology, by
seeking to add new biological parts to systems, seeks a greater depth of
modification of organisms than previous technologies, such as genetic
engineer.
– Familiarity: as organisms (particularly orthogonal approaches to synthetic
biology) diverge from natural organisms, our ability to assess risks based on
similarity with natural systems diminishes. Some do argue that more
divergent organisms are in fact safer because they cannot directly interact on
a genetic level with natural systems.
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When it comes to public perception, however, Pardo Avellaneda and Hagen’s
chapter Synthetic Biology: Public Perceptions of an Emergent Field, highlights
the low salience of the topic with the public. As they note, this is not uncommon.
‘Most scientific developments take place silently, contributing to the continuous
expansion of knowledge but known only to the corresponding subsets of the
scientific community’ (p. 135). Synthetic biology is at an early stage of
development, it has not yet produced any notable ‘products’ or practical
developments that might capture public attention. The field is complex, presenting
barriers to communication, so it is not surprising that it remains relatively
infrequently reported. Pardo Avellaneda and Hagen argue that given the recent
experience of public (non)acceptance of biotechnology, now is the time to begin a
public conversation about synthetic biology. As is apparent from the wide range of
issues addressed in this book, a public discussion is needed to ensure that synthetic
biology travels in a publicly acceptable direction. The Responsible Research and
Innovation (RRI) agenda demands this level of public and policy engagement.
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